Senior VP Sean Mackay Sells 25,729 Shares Amid Sharp Drop at Standard BioTools Inc.
Insider sale by Standard BioTools’ SVP Sean Mackay shows routine liquidity moves, not a confidence drop—watch the next earnings for clues.
3 minutes to read
STANDARD BIOTOOLS INC
Standard BioTools Insider Thomas D. Buys Big: 99K RSUs + 264K Options Signaling Confidence in a 27‑Month Decline Recovery
Carey Thomas D.’s recent insider purchase signals confidence in Standard BioTools’ future—RSUs and options could drive a rebound after a 27‑month decline.
4 minutes to read
CEO of Standard BioTools Amasses 1.04 M Zero‑Cost Shares, Signaling Long‑Term Confidence in Company’s Growth Trajectory
CEO Michael Egholm’s zero‑cost RSU purchases show strong insider confidence in Standard BioTools, signaling a long‑term growth bet and a potential catalyst for investor interest.
4 minutes to read
Standard BioTools CEO’s RSU Purchase Signals Long‑Term Confidence Amid Mixed Insider Trading Wave
Insider confidence drives Standard BioTools shares up—Casdin Eli buys 53k shares at $1.17 amid mixed exec sales, hinting at future growth in diagnostics and micro‑fluidics.
2 minutes to read
Insider Buying at Standard BioTools Signals Confidence Amid CEO Sell‑Offs
Insider buying signals confidence in Standard BioTools – executives’ RSU purchase after earnings shows long‑term commitment and may hint at future upside as R&D matures.
2 minutes to read